Search
for
Sort by
Research 271–300 of 1000+
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Retrospective Evaluation of the Impact of the COVID-19 Pandemic on the Incidence of Alopecia Areata in a Single Dermatological Department
- Review of Promising Off-Label Use of Deucravacitinib
- Special collection on inward rectifying K<sup>+</sup> channels
- Cutaneous Manifestations of COVID-19
- Effects of microenvironment and biological behavior on the paracrine function of stem cells
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Gut microbiome, metabolome and alopecia areata
- A complete guide to human microbiomes: Body niches, transmission, development, dysbiosis, and restoration
- Trichoscopy as a diagnostic tool in trichorrhexis invaginata and Netherton syndrome
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Understanding the Secular Decline in Testosterone: Mechanisms, Consequences, and Clinical Perspectives
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- Poster Presentations
- Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
- Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata
- Exploring novel management options for alopecia areata
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- The most recent advances in understanding and managing hidradenitis suppurativa
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- Mesenchymal Stem Cell-Derived Extracellular Vesicles for Therapeutic Use and in Bioengineering Applications
- Pollen Allergies in Humans and their Dogs, Cats and Horses: Differences and Similarities
- Off-label dermatologic uses of IL-23 inhibitors
- Skin applications of cannabidiol: sources, effects, delivery systems, marketed formulations and safety
- Hypothalamic-pituitary-adrenal axis, hair, and sebum: Stress-mediated dermatologic disasters of the pandemic era
- Stem Cell Use to Treat Dermatological Disorders